Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze MCRB stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate MCRB investment potential.

What is MCRB stock price today?

Get real-time MCRB stock price, historical data, and price charts on Financhill. Track MCRB performance with our advanced analysis tools.

Is MCRB a good investment?

Evaluate MCRB investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy MCRB stock?

To buy MCRB stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of MCRB?

View detailed market capitalization data and company valuation metrics for MCRB on our comprehensive analysis page.

What is the P/E ratio of MCRB?

Use our fundamental analysis tools to view MCRB P/E ratio and compare valuation metrics with industry peers.

What are MCRB earnings?

View MCRB earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Seres Therapeutics, Inc. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

MCRB
Seres Therapeutics, Inc.

Last Price:

$16.49

Seasonality Move:

-18.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

Seres Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 15.6% based on the past 10 years of stock performance.
Seres Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%
Is Seres Therapeutics, Inc. Stock Undervalued?

The current Seres Therapeutics, Inc. [MCRB] share price is $16.94. The Score for MCRB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
MCRB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Seres Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, Seres Therapeutics, Inc. has on average historically risen by 15.6% based on the past 10 years of stock performance.

Seres Therapeutics, Inc. Stock Rating

Sell

Seres Therapeutics, Inc. (MCRB) is a Sell

Is Seres Therapeutics, Inc. overpriced?

Seres Therapeutics, Inc. has risen higher in 2 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 20%

Seres Therapeutics, Inc. Stock Price History

Is MCRB stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

serestherapeutics.com

52-Week Data

52-Week High:

29.98

52-Week Low:

6.53

Prediction Charts

Market Cap:

148.3M

Price in USD:

16.94

Volume:

44.9K

Beta:

2.07

Technical Analysis

SMA50:

17.86

SMA100:

17.52

SMA200:

14.10

52-Wk Change:

-1.57%

Stock Predictions

Is Seres Therapeutics, Inc. stock public?

Yes, Seres Therapeutics, Inc. is a publicly traded company.
What is the Seres Therapeutics, Inc. stock quote today?

The Seres Therapeutics, Inc. stock price is 16.94 USD today.
How to buy Seres Therapeutics, Inc. stock online?

You can buy Seres Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-24	17.65	16.97	18.27	16.30
Nov-25	16.97	16.92	17.60	16.54
Nov-26	16.90	16.87	17.27	16.51
Nov-28	16.75	17.99	18.40	16.75
Dec-1	17.50	17.34	18.86	17.00
Dec-2	16.96	16.70	18.00	16.61
Dec-3	16.96	17.44	17.95	16.87
Dec-4	17.50	17.90	17.90	16.80
Dec-5	17.78	16.66	17.90	16.53
Dec-8	16.87	17.18	17.42	16.60
Dec-9	17.03	16.78	17.52	16.55
Dec-10	16.74	16.98	17.12	16.50
Dec-11	17.08	17.16	17.30	16.95
Dec-12	17.27	16.94	17.90	16.89

Seres Therapeutics, Inc. Earnings

Seres Therapeutics, Inc. Earnings Report: Per Share Seres Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Seres Therapeutics, Inc. Forecast Revenue Growth

Seres Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Seres Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $4.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $8.94 per share, and a decrease next year of $11.20 per share.

* Seres Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.